NABOTA is the high-purity product developed independently by
Daewoong Pharmaceutical and minimized the side effect that may be
caused by the diffusion into other tissues from
the site of injection.
Daewoong Pharmaceutical has obtained the approval of the Ministry
of Food
and Drug Safety for NABOTA, slated for release in U.S domestic
market
www.kbeautypharm.com
#804, 13 Beobwon-ro 8-gil, Songpa-gu, Seoul, Republic of Korea (Zip Code 05855)